2. Membrane Transporter/Ion Channel Neuronal Signaling
  3. TRP Channel
  4. JD03-02

JD03-02 is an orally active, blood-brain barrier-permeable TRPC1/5 heterodimer inhibitor with an IC50 of 0.2 nM. JD03-02 preferentially binds to a unique ligand-binding pocket at the interface of TRPC1-TRPC5, exerts almost no inhibitory effect on TRPC5 homotetramers, and thus avoids side effects such as obesity and hyperkinesia. JD03-02 induces anxiolytic and antidepressant effects in mouse models. JD03-02 can be used in studies related to depression and anxiety disorders.

For research use only. We do not sell to patients.

JD03-02

JD03-02 Chemical Structure

Size Stock
50 mg   Get quote  
100 mg   Get quote  
250 mg   Get quote  

* Please select Quantity before adding items.

This product is a controlled substance and not for sale in your territory.

JD03-02 Related Antibodies

Top Publications Citing Use of Products

View All TRP Channel Isoform Specific Products:

View All Isoforms
TRPA1 TRPC3 TRPC4 TRPC5 TRPC6 TRPC7 TRPM8 TRPM2 TRPM3 TRPM4 TRPM7 TRPML1 TRPML2 TRPML3 TRPV1 TRPV2 TRPV3 TRPV4 TRPV6

  • Biological Activity

  • Purity & Documentation

  • References

  • Customer Review

Description

JD03-02 is an orally active, blood-brain barrier-permeable TRPC1/5 heterodimer inhibitor with an IC50 of 0.2 nM. JD03-02 preferentially binds to a unique ligand-binding pocket at the interface of TRPC1-TRPC5, exerts almost no inhibitory effect on TRPC5 homotetramers, and thus avoids side effects such as obesity and hyperkinesia. JD03-02 induces anxiolytic and antidepressant effects in mouse models. JD03-02 can be used in studies related to depression and anxiety disorders[1].

IC50 & Target[1]

TRPC1/5

0.2 nM (IC50)

TRPC1/4

6.7 nM (IC50)

TRPC5

8504 nM (IC50)

TRPC4

2385 nM (IC50)

In Vitro

JD03-02 (10 μM) potently inhibits TRPC1/5 heteromer-mediated calcium influx in HEK293T cells, whereas it exerts no effect on TRPC5 homomers at the concentration of 10 μM[1].
JD03-02 potently inhibits TRPC1/5 heteromers in HEK293T cells with an IC50 of 0.2 nM, and exhibits over 10000-fold selectivity over TRPC5 homomers (IC50 = 8504 nM)[1].
JD03-02 inhibits TRPC1/4 heteromers in HEK293T cells with an IC50 of 6.7 nM, and exhibits selectivity for TRPC4 homomers (IC50 = 2385 nM)[1].
JD03-02 (10 μM) exhibits only extremely low activity against human TRPC3, TRPC6 and TRPC7, with an inhibition rate of no more than 40% at a concentration of 10 μM[1].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

JD03-02 Related Antibodies
In Vivo

JD03-02 (3-30 mg/kg; p.o.; once daily; for 14 consecutive days) exerts rapid and sustained dose-dependent antidepressant efficacy in chronic unpredictable mild stress (CUMS)-induced depression-like mice[1].
JD03-02 (3-30 mg/kg; p.o.; single administration) exerts dose-dependent anxiolytic effects in mCPP (HY-101324)-induced anxiety-like mice[1].
JD03-02 (10 mg/kg; p.o.; once daily; 11 days) does not induce weight gain or hyperphagia in diet-induced obese mice[1].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model: C57BL/6J (male, 7-8 weeks old, chronic unpredictable mild stress-induced depression model)[1]
Dosage: 3 mg/kg; 10 mg/kg; 30 mg/kg (single dose; daily for 14 days)
Administration: p.o.; daily (14 days); single dose
Result: Significantly increased sucrose preference compared to vehicle control after a single 30 mg/kg dose.
Significantly increased sucrose preference compared to vehicle control after 11 days of daily treatment with 3 mg/kg, 10 mg/kg, and 30 mg/kg doses, with the 30 mg/kg dose showing greater improvement than the 3 mg/kg dose.
Significantly reduced immobility time in the forced swim test compared to vehicle control after 14 days of daily treatment with 3 mg/kg, 10 mg/kg, and 30 mg/kg doses, with the 30 mg/kg dose showing greater improvement than the 3 mg/kg dose.
Animal Model: C57BL/6J (male, 7-8 weeks old, mCPP-induced anxiety model)[1]
Dosage: 3 mg/kg; 10 mg/kg; 30 mg/kg
Administration: p.o.; single dose
Result: Dose-dependently increased open arm entries and time spent in open arms in the elevated plus maze compared to vehicle control.
Dose-dependently reduced the number of marbles buried in the marble burying test compared to vehicle control.
Dose-dependently increased central zone entries and time spent in the central zone in the open field test compared to vehicle control.
Showed significantly superior efficacy to diazepam in the open field test at 30 mg/kg.
Animal Model: C57BL/6J (male, 14 weeks old, high-fat diet-induced obesity model)[1]
Dosage: 10 mg/kg
Administration: p.o.; daily; 11 days
Result: Had no significant effect on body weight compared to vehicle control.
Had no significant effect on daily or cumulative food intake compared to vehicle control.
Molecular Weight

516.42

Formula

C25H27Cl2N5O3
SMILES

CN(CCCCN1C(C2=C(N(C1=O)C)N=C(N2CC3=CC=C(C=C3)Cl)OC4=CC=CC(Cl)=C4)=O)C
Shipping

Room temperature in continental US; may vary elsewhere.
Storage

Please store the product under the recommended conditions in the Certificate of Analysis.
Purity & Documentation
References
  • No file chosen (Maximum size is: 1024 Kb)
  • If you have published this work, please enter the PubMed ID.
  • Your name will appear on the site.

JD03-02 Related Classifications

  • Molarity Calculator

  • Dilution Calculator

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

Mass   Concentration   Volume   Molecular Weight *
= × ×

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
× = ×
C1   V1   C2   V2
Help & FAQs
  • Do most proteins show cross-species activity?

    Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

Keywords:

JD03-02TRP ChannelTransient receptor potential channelsHEK293T cellsTRPC3TRPC6TRPC1/4 heteromersdepressionanxietyTRPC4 homomersmouse modelsTRPC5 homomersTRPC1/5 heteromerInhibitorinhibitorinhibit

Your Recently Viewed Products:

Inquiry Online

Your information is safe with us. * Required Fields.

Product Name

  

Requested Quantity *

Applicant Name *

 

Salutation

Email Address *

 

Phone Number *

Department

 

Organization Name *

City

State

Country or Region *

      

Remarks

Bulk Inquiry

Inquiry Information

Product Name:
JD03-02
Cat. No.:
HY-184164
Quantity:
MCE Japan Authorized Agent:

Customer Review

Thank You for Your Feedback!

Request for HNMR Report

Please fill out this form to request the QC report. We will send it to your Email address shortly.

Your information is safe with us. * Required Fields.

Product Name

  

Lot #

Applicant Name *

 

Email Address *

Phone Number

 

Department *

Organization Name *

 

Country or Region *

Remarks

SAFETY DATA SHEET (SDS)

Request for HNMR Report

We have received your request and will respond to you as soon as possible.